Ultragenyx Enters into Strategic Partnership with Daiichi Sankyo for Gene Therapy Manufacturing Technology

Ads

You May Also Like

New Veterinarian Joins Blue Valley Animal Hospital

OVERLAND PARK, Kan., Sept. 6, 2015 (GLOBE NEWSWIRE) -- Blue Valley Animal Hospital announced ...

Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology

Additional analysis from pivotal Phase III SOLAR-1 clinical trial studying investigational alpha-specific PI3K inhibitor ...

Nexvet Biopharma Reports Full Year Fiscal 2016 Results

DUBLIN, Ireland, Sept. 02, 2016 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic ...